Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor necrosis factor-beta and hypercalcemia.

K Ishibashi1, M Kodama, S Hanada

  • 1Second Department of Internal Medicine, Faculty of Medicine, Kagoshima University, Japan.

Leukemia & Lymphoma
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrically Controlled Nonlinear Magnon-Magnon Coupling in a Synthetic Antiferromagnet.

Physical review letters·2025
Same author

Combined Exercise and Education Program: Effect of Smaller Group Size and Longer Duration on Physical Function and Social Engagement among Community-Dwelling Older Adults.

JAR life·2023
Same author

An artificial impact on the asteroid (162173) Ryugu formed a crater in the gravity-dominated regime.

Science (New York, N.Y.)·2020
Same author

A new decompression device for treating odontogenic cysts using a silicone tube.

The British journal of oral & maxillofacial surgery·2019
Same author

Vascular endothelial growth factors C and D and lymphangiogenesis at the early stage of esophageal squamous cell carcinoma progression.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2018
Same author

Anti-platelet effects of chalcones from <i>Angelica keiskei</i> Koidzumi (Ashitaba) <i>in vivo</i>.

Die Pharmazie·2018
Same journal

Extending the prognostic value of red cell distribution width to nodal T follicular helper cell lymphoma.

Leukemia & lymphoma·2026
Same journal

Durable response to salvage gilteritinib, allogeneic stem cell rescue and maintenance therapy in relapsed AML with a <i>FLT3</i> N676K variant.

Leukemia & lymphoma·2026
Same journal

Glofitamab for the treatment of relapsed/refractory hairy cell leukemia: a case report.

Leukemia & lymphoma·2026
Same journal

Pre- and post-transplant serum albumin levels and outcomes after allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia.

Leukemia & lymphoma·2026
Same journal

Leukemia mortality analysis in the pediatric population in São Paulo state, Brazil, 2000-2019.

Leukemia & lymphoma·2026
Same journal

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Leukemia & lymphoma·2026
See all related articles

Tumor necrosis factor-beta (TNF-beta) contributes to hypercalcemia in adult T-cell leukemia (ATL). This study confirms TNF-beta

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Hypercalcemia is a common complication in hematological malignancies, particularly lymphoid malignancies like adult T-cell leukemia (ATL) and multiple myeloma.
  • Managing hypercalcemia in these conditions presents significant clinical challenges.

Purpose of the Study:

  • To investigate the role of tumor necrosis factor-beta (TNF-beta), also known as lymphotoxin, as a causative agent of hypercalcemia in ATL.
  • To confirm the presence and activity of TNF-beta in ATL patients and associated cell lines.

Main Methods:

  • Bone resorption studies using culture supernatants from HTLV-I infected cells.
  • Enzyme-linked immunosorbent assays (ELISA) to quantify TNF-beta levels in patient sera.
  • Immunostaining with monoclonal anti-TNF-beta antibody on cell lines and primary ATL cells.

Related Experiment Videos

  • Biological TNF-beta activity assays, including antibody inhibition studies.

    • Main Results:

    • Elevated TNF-beta levels were detected in the sera of ATL patients with hypercalcemia.
    • TNF-beta was identified within HTLV-I infected cell lines and freshly isolated ATL cells.
    • Confirmed TNF-beta activity in patient sera and cell culture supernatants, demonstrating its osteoclast activating factor (OAF) function.

    Conclusions:

    • Secreted TNF-beta from ATL cells is a significant contributing factor to hypercalcemia in ATL patients.
    • TNF-beta acts as an osteoclast activating factor (OAF), promoting bone resorption and calcium release.
    • These findings highlight TNF-beta as a potential therapeutic target for managing hypercalcemia in ATL.